ifosfamide has been researched along with Experimental Hepatoma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ifosfamide is an oxazaphosphorine alkylating agent with a broad spectrum of antineoplastic activity." | 1.35 | Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy. ( Wang, X; Xu, T; Zhang, J, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X | 1 |
| Zhang, J | 1 |
| Xu, T | 1 |
| Wolff, M | 1 |
| Jelkmann, W | 1 |
2 other studies available for ifosfamide and Experimental Hepatoma
| Article | Year |
|---|---|
Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy.
Topics: Animals; Antineoplastic Agents, Alkylating; Ascites; Cell Cycle; Cell Proliferation; G1 Phase; Ifosf | 2008 |
Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.
Topics: Animals; Antineoplastic Agents; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Cytarabine | 1993 |